What is a stock summary page? Click here for an overview.
Business Description
XBiotech Inc
NAICS : 325412
SIC : 3741
ISIN : CA98400H1029
Compare
Compare
Traded in other countries / regions
XBIT.USA4XB.Germany Index Membership
Russell 2000Russell 3000Russell 2000 IPO Date
2015-04-15Description
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 18.31 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.21 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -31.2 | |||||
| 3-Year EPS without NRI Growth Rate | -23.2 | |||||
| 3-Year FCF Growth Rate | 34.5 | |||||
| 3-Year Book Growth Rate | -15.5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.7 | |||||
| 9-Day RSI | 50.56 | |||||
| 14-Day RSI | 46.16 | |||||
| 3-1 Month Momentum % | -53.81 | |||||
| 6-1 Month Momentum % | -54.53 | |||||
| 12-1 Month Momentum % | -49.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.57 | |||||
| Quick Ratio | 11.57 | |||||
| Cash Ratio | 11.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.3 | |||||
| Shareholder Yield % | -0.05 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -15.71 | |||||
| ROA % | -14.72 | |||||
| ROIC % | -135.94 | |||||
| 3-Year ROIIC % | 25.06 | |||||
| ROC (Joel Greenblatt) % | -194.79 | |||||
| ROCE % | -23.16 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 3.17 | |||||
| PB Ratio | 0.5 | |||||
| Price-to-Tangible-Book | 0.5 | |||||
| EV-to-EBIT | 1.5 | |||||
| EV-to-EBITDA | 1.56 | |||||
| EV-to-FCF | 2.49 | |||||
| Price-to-GF-Value | 19.63 | |||||
| Price-to-Projected-FCF | 6.16 | |||||
| Price-to-Net-Current-Asset-Value | 0.57 | |||||
| Price-to-Net-Cash | 0.58 | |||||
| Earnings Yield (Greenblatt) % | 66.67 | |||||
| FCF Yield % | -30.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:XBIT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
XBiotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.08 | ||
| Beta | 0.88 | ||
| 3-Year Sharpe Ratio | -0.17 | ||
| 3-Year Sortino Ratio | -0.26 | ||
| Volatility % | 90.77 | ||
| 14-Day RSI | 46.16 | ||
| 14-Day ATR ($) | 0.226296 | ||
| 20-Day SMA ($) | 3.1865 | ||
| 12-1 Month Momentum % | -49.13 | ||
| 52-Week Range ($) | 2.94 - 9.96 | ||
| Shares Outstanding (Mil) | 30.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
XBiotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
XBiotech Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
XBiotech Inc Frequently Asked Questions
What is XBiotech Inc(XBIT)'s stock price today?
The current price of XBIT is $3.14. The 52 week high of XBIT is $9.96 and 52 week low is $2.94.
When is next earnings date of XBiotech Inc(XBIT)?
The next earnings date of XBiotech Inc(XBIT) is 2025-05-09 Est..
Does XBiotech Inc(XBIT) pay dividends? If so, how much?
XBiotech Inc(XBIT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers